Adagene Inc (ADAG)
2.53
-0.04
(-1.56%)
USD |
NASDAQ |
May 17, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
Adagene Debt to Equity Ratio: 0.3109 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3109 |
| June 30, 2023 | 0.3012 |
| December 31, 2022 | 0.3342 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.1471 |
| December 31, 2021 | 0.0478 |
| June 30, 2021 | 0.0412 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0412
Minimum
Jun 2021
0.3342
Maximum
Dec 2022
0.1971
Average
0.2242
Median
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0292 |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.0633 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| YS Biopharma Co Ltd | 0.9778 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 115.73M |
| Total Liabilities (Quarterly) | 45.17M |
| Shareholders Equity (Quarterly) | 70.56M |
| Current Ratio | 3.606 |
| Net Debt Paydown Yield | -2.10% |